SpectraCure AB Cash Flow-to-Debt Ratio
SpectraCure AB cash flow-to-debt ratio. SpectraCure AB (SPEC) has a Cash Flow-to-Debt Ratio of -0.41x as of December 2025, meaning its operating cash flow of Skr-4.48 Million could theoretically repay 0% of its total liabilities (Skr10.92 Million) in one year. See SpectraCure AB free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of SpectraCure AB (2014–2025)
Cash flow-to-debt ratio of SpectraCure AB from 2014 to 2025. Historical debt coverage capacity for SpectraCure AB across 12 annual periods. Check SpectraCure AB investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
SpectraCure AB Cash Flow-to-Debt Ratio by Year (2014–2025)
SpectraCure AB cash flow-to-debt ratio by year from 2014 to 2025. Year-by-year debt coverage analysis for SpectraCure AB. For the full cash flow conversion analysis, see SpectraCure AB (SPEC) cash flow conversion.
| Year | CF-to-Debt Ratio | Operating CF (SEK) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -2.20x | Skr-24.03 Million | Skr10.92 Million | ▼ -42.6% |
| 2024 | -1.54x | Skr-21.83 Million | Skr14.15 Million | ▼ -23.7% |
| 2023 | -1.25x | Skr-18.68 Million | Skr14.97 Million | ▲ +34.2% |
| 2022 | -1.89x | Skr-22.96 Million | Skr12.12 Million | ▼ -51.1% |
| 2021 | -1.25x | Skr-18.60 Million | Skr14.84 Million | ▼ -77.5% |
| 2020 | -0.71x | Skr-9.40 Million | Skr13.32 Million | ▲ +12.8% |
| 2019 | -0.81x | Skr-10.05 Million | Skr12.41 Million | ▲ +63.6% |
| 2018 | -2.23x | Skr-8.97 Million | Skr4.03 Million | ▼ -145.8% |
| 2017 | 4.86x | Skr6.33 Million | Skr1.30 Million | ▲ +265.2% |
| 2016 | -2.94x | Skr-19.60 Million | Skr6.66 Million | ▲ +68.6% |
| 2015 | -9.38x | Skr-9.71 Million | Skr1.04 Million | ▼ -13341.8% |
| 2014 | -0.07x | Skr-604.49K | Skr8.66 Million | — |